The Multi-Kinase Inhibitor Lucitanib Enhances the Antitumor Activity of Coinhibitory and Costimulatory Immune Pathway Modulators in Syngeneic Models. - Robillard L; Liao M; Nguyen M; Harding TC; Simmons AD; Dusek RL (Journal of immunotherapy (Hagerstown, Md. : 1997), 2022)